Orthopaedic Associates of Hartford, Hartford Healthcare Bone and Joint Institute.
Research Department, Hartford HealthCare Bone and Joint Institute, Hartford.
Clin Spine Surg. 2023 May 1;36(4):E131-E134. doi: 10.1097/BSD.0000000000001387. Epub 2022 Sep 13.
Retrospective.
The purpose of this study was to determine the utility of the erector spinae plane regional anesthesia (ESP) block in reducing opioid medication usage and postanesthesia care unit length of stay (PACU-LOS) for patients undergoing either a posterior or transforaminal lumbar interbody fusions (PLIF/TLIF).
Posterior lumbar spine fusion is a common surgical procedure typically associated with significant postoperative pain. Poorly controlled postoperative pain can lead to a number of poor outcomes. Although opioids are a mainstay for pain control, they are associated with adverse effects and a risk of dependence. Therefore, multimodal pain control has become more prevalent in orthopedics and combines traditional opioid and nonopioid pain mediation with general anesthesia protocols and regional nerve blocks.
A retrospective chart review was conducted for patients undergoing PLIFs or TLIFs between 2019 and 2021. Patients were placed into 2 groups, those receiving an ESP block and those that did not. T tests assuming unequal variances were used to assess differences in pain scores, opioid consumption, and PACU-LOS between groups.
The study group demonstrated a 35% reduction in opioid use ( P =0.016), a 16% reduction in pain with activity ( P =0.042), and a 9.7% reduction in pain at rest ( P =0.219) compared with the control group. There were no significant differences in PACU-LOS between groups ( P =0.314).
The use of an ESP block for patients undergoing PLIFs and TLIFs appears to be a safe and effective means to manage postoperative pain and reduce opioid consumption.
回顾性研究。
本研究旨在确定竖脊肌平面区域阻滞(ESP 阻滞)在减少接受后路或经椎间孔腰椎体间融合术(PLIF/TLIF)患者的阿片类药物使用量和术后恢复室(PACU)停留时间(LOS)方面的作用。
后路腰椎融合术是一种常见的手术,通常与明显的术后疼痛相关。术后疼痛控制不佳可能导致多种不良后果。尽管阿片类药物是控制疼痛的主要药物,但它们与不良反应和依赖风险相关。因此,多模式疼痛控制在骨科中越来越普遍,将传统的阿片类和非阿片类疼痛调节与全身麻醉方案和区域神经阻滞相结合。
对 2019 年至 2021 年间接受 PLIF 或 TLIF 的患者进行回顾性图表审查。患者分为接受 ESP 阻滞和未接受 ESP 阻滞两组。使用方差不均等的 t 检验评估两组之间疼痛评分、阿片类药物使用量和 PACU-LOS 的差异。
与对照组相比,研究组的阿片类药物使用量减少了 35%(P=0.016),活动时疼痛减轻了 16%(P=0.042),休息时疼痛减轻了 9.7%(P=0.219)。两组间 PACU-LOS 无显著差异(P=0.314)。
对于接受 PLIF 和 TLIF 的患者,使用 ESP 阻滞似乎是一种安全有效的管理术后疼痛和减少阿片类药物使用的方法。